NDC 31722-753 – Lamivudine

Lamivudine 150 mg/1 · Tablet, Film Coated · Oral

Human Prescription Drug

Product NDC31722-753

Product details

Brand name
Lamivudine
Generic name
Lamivudine
Labeler
Camber Pharmaceuticals, Inc.
Dosage form
Tablet, Film Coated
Route
Oral
Marketing category
ANDA · ANDA203277
Marketed since
January 6, 2014
Listing expires
December 31, 2026
Pharmacologic class
Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor; Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor

Active ingredients

Uses, dosage, side effects and warnings for Lamivudine →

Package NDC codes (4)

Package NDCDescriptionSince
31722-753-06600 TABLET, FILM COATED in 1 BOTTLE (31722-753-06)Jan 6, 2014
31722-753-3110 TABLET, FILM COATED in 1 BLISTER PACK (31722-753-31)Jan 6, 2014
31722-753-32100 TABLET, FILM COATED in 1 CARTON (31722-753-32)Jan 6, 2014
31722-753-6060 TABLET, FILM COATED in 1 BOTTLE (31722-753-60)Jan 6, 2014

Other Lamivudine products